CZ281937B6 - Substituované bifenylpyridony - Google Patents

Substituované bifenylpyridony Download PDF

Info

Publication number
CZ281937B6
CZ281937B6 CS923380A CS338092A CZ281937B6 CZ 281937 B6 CZ281937 B6 CZ 281937B6 CS 923380 A CS923380 A CS 923380A CS 338092 A CS338092 A CS 338092A CZ 281937 B6 CZ281937 B6 CZ 281937B6
Authority
CZ
Czechia
Prior art keywords
group
carbon atoms
straight
branched alkyl
optionally substituted
Prior art date
Application number
CS923380A
Other languages
Czech (cs)
English (en)
Inventor
Mathias Dr. Müller-Gliemann
Martin Dr. Beuck
Stanislav Prof. Dr. Kazda
Johannes Peter Dr. Stasch
Stefan Dr. Wohlfeil
Walter Dr. Hübsch
Jürgen Dressel Ph.D.
Peter Dr. Fey
Rudolf Dr. Hanko
Thomas Dr. Krämer
Ulrich Dr. Müller
Siegfried Dr. Zaiss
Andreas Dr. Knorr
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of CZ338092A3 publication Critical patent/CZ338092A3/cs
Publication of CZ281937B6 publication Critical patent/CZ281937B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
CS923380A 1991-11-12 1992-11-12 Substituované bifenylpyridony CZ281937B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4137151 1991-11-12
DE4221583A DE4221583A1 (de) 1991-11-12 1992-07-01 Substituierte biphenylpyridone

Publications (2)

Publication Number Publication Date
CZ338092A3 CZ338092A3 (en) 1993-09-15
CZ281937B6 true CZ281937B6 (cs) 1997-04-16

Family

ID=25909023

Family Applications (1)

Application Number Title Priority Date Filing Date
CS923380A CZ281937B6 (cs) 1991-11-12 1992-11-12 Substituované bifenylpyridony

Country Status (23)

Country Link
US (2) US5356911A (cg-RX-API-DMAC7.html)
EP (1) EP0542059B1 (cg-RX-API-DMAC7.html)
JP (1) JPH05255258A (cg-RX-API-DMAC7.html)
KR (1) KR930010030A (cg-RX-API-DMAC7.html)
CN (1) CN1038935C (cg-RX-API-DMAC7.html)
AT (1) ATE135700T1 (cg-RX-API-DMAC7.html)
AU (1) AU659235B2 (cg-RX-API-DMAC7.html)
CA (1) CA2082306A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ281937B6 (cg-RX-API-DMAC7.html)
DE (2) DE4221583A1 (cg-RX-API-DMAC7.html)
DK (1) DK0542059T3 (cg-RX-API-DMAC7.html)
ES (1) ES2086046T3 (cg-RX-API-DMAC7.html)
FI (1) FI925100L (cg-RX-API-DMAC7.html)
GR (1) GR3019398T3 (cg-RX-API-DMAC7.html)
HU (1) HUT67018A (cg-RX-API-DMAC7.html)
IL (1) IL103688A (cg-RX-API-DMAC7.html)
MX (1) MX9206305A (cg-RX-API-DMAC7.html)
MY (1) MY109880A (cg-RX-API-DMAC7.html)
NO (1) NO303541B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ245073A (cg-RX-API-DMAC7.html)
RU (1) RU2100350C1 (cg-RX-API-DMAC7.html)
SK (1) SK279433B6 (cg-RX-API-DMAC7.html)
TW (1) TW218874B (cg-RX-API-DMAC7.html)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine
US5674883A (en) * 1992-02-07 1997-10-07 Roussel Uclaf Derivatives of pyridone, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
DE4319041A1 (de) * 1992-10-23 1994-04-28 Bayer Ag Trisubstituierte Biphenyle
DE4319040A1 (de) * 1992-10-23 1994-04-28 Bayer Ag Alkoxymethylsubstituierte Pyridonbiphenyle
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
TW418204B (en) * 1997-03-28 2001-01-11 Dev Center Biotechnology Novel 1,2,4-triazine-5-ketonyl benzene derivatives and the analogs, the preparation, and the pharmaceutical compositions as angiotension II receptor antogonists
HU222773B1 (hu) * 2000-04-21 2003-10-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás egy ismert tetrazolszármazék előállítására
GB0022483D0 (en) * 2000-09-13 2000-11-01 Eisai Co Ltd 1 2 Dihydropyridine compounds manufacturing method thereof and use thereof
JP5082033B2 (ja) * 2001-12-21 2012-11-28 エグゼリクシス パテント カンパニー エルエルシー Lxrのモジュレーター
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
DE60330126D1 (de) * 2002-02-14 2009-12-31 Pharmacia Corp Substituierte pyridinone als modulatoren für p38 map kinase
EP1628970A2 (en) * 2003-04-30 2006-03-01 The Institutes of Pharmaceutical Discovery, LLC Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
MY148809A (en) * 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US20060122222A1 (en) * 2004-11-18 2006-06-08 The Institutes For Pharmaceutical Discovery, Llc Heterocycle substituted carboxylic acids
CA2591413A1 (en) * 2004-12-16 2006-06-22 Vertex Pharmaceuticals Incorporated Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases
DE102005030522A1 (de) * 2005-06-30 2007-01-04 Bayer Healthcare Ag Salz des Embusartans
EP1919906B1 (en) 2005-08-29 2011-10-12 Vertex Pharmaceuticals Incorporated 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
ATE548363T1 (de) * 2005-08-29 2012-03-15 Vertex Pharma 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
JP5112317B2 (ja) * 2005-08-29 2013-01-09 バーテックス ファーマシューティカルズ インコーポレイテッド 非受容体型チロシンキナーゼのtecファミリーの阻害剤として有用な3,5−二置換ピリド−2−オン
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
ES2559319T3 (es) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2203439B1 (en) 2007-09-14 2011-01-26 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
EP2205565B1 (en) 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
WO2009033702A1 (en) 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
EP2220083B1 (en) * 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
JP5656848B2 (ja) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体
EP2373649B1 (en) 2008-11-28 2013-01-23 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010130424A1 (en) 2009-05-12 2010-11-18 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
PL2496236T4 (pl) * 2009-11-06 2015-11-30 Aerpio Therapeutics Inc Inhibitory hydroksylazy prolilowej
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
JP6137193B2 (ja) * 2011-12-21 2017-05-31 小野薬品工業株式会社 第XIa因子阻害剤としての新規ピリジノンおよびピリミジノン誘導体
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
MX386697B (es) 2014-01-21 2025-03-19 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
EP3702357B1 (en) 2014-12-10 2022-08-24 ONO Pharmaceutical Co., Ltd. Dihydroindolizinone derivative
US10322156B2 (en) * 2016-07-07 2019-06-18 Herbalife International Of America, Inc. Methods of treatment using purified (decolorized) aloe vera leaf dry juice
EP4288430A1 (en) 2021-02-02 2023-12-13 Liminal Biosciences Limited Gpr84 antagonists and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0424317A3 (en) 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
CA2037630C (en) 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
KR100196559B1 (ko) * 1990-06-19 1999-06-15 기따사또 이찌로 안지오텐신ii 길항작용을 함유하는 피리딘 유도체
IL100917A0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
CN1068109A (zh) * 1991-02-16 1993-01-20 菲索斯有限公司 新的血管紧张肽ii拮抗剂及其制剂的制备和应用
DE4129340A1 (de) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-oxopyridine

Also Published As

Publication number Publication date
KR930010030A (ko) 1993-06-21
DE4221583A1 (de) 1993-05-13
AU659235B2 (en) 1995-05-11
MX9206305A (es) 1993-05-01
CN1072180A (zh) 1993-05-19
NZ245073A (en) 1996-02-27
CZ338092A3 (en) 1993-09-15
FI925100A7 (fi) 1993-05-13
CA2082306A1 (en) 1993-05-12
NO924172D0 (no) 1992-10-29
US5356911A (en) 1994-10-18
ES2086046T3 (es) 1996-06-16
CN1038935C (zh) 1998-07-01
TW218874B (cg-RX-API-DMAC7.html) 1994-01-11
IL103688A (en) 1997-02-18
FI925100L (fi) 1993-05-13
JPH05255258A (ja) 1993-10-05
RU2100350C1 (ru) 1997-12-27
NO303541B1 (no) 1998-07-27
EP0542059B1 (de) 1996-03-20
HU9203552D0 (en) 1993-01-28
SK338092A3 (en) 1998-11-04
SK279433B6 (sk) 1998-11-04
ATE135700T1 (de) 1996-04-15
HUT67018A (en) 1995-01-30
DK0542059T3 (da) 1996-07-22
IL103688A0 (en) 1993-04-04
FI925100A0 (fi) 1992-11-10
AU2823292A (en) 1993-05-13
NO924172L (no) 1993-05-14
DE59205752D1 (de) 1996-04-25
GR3019398T3 (en) 1996-06-30
US5599823A (en) 1997-02-04
EP0542059A1 (de) 1993-05-19
MY109880A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
CZ281937B6 (cs) Substituované bifenylpyridony
CZ15793A3 (en) Sulfonylbenzyl-substituted pyridones
CZ280248B6 (cs) Substituované azoly, způsob jejich výroby, přípravky obsahující tyto sloučeniny a jejich použití
HU225052B1 (en) Cycloalkano-indol- and -azaindol derivatives process for producing them and pharmaceutical compositions containing the same
SK15294A3 (en) Heterocyclic substituted derivatives of phenyl-cyclohexane carboxyle acid
CZ297692A3 (en) Substituted derivatives of imidazolyl-propenoic acid
CZ29793A3 (en) Phenylacetic acid substituted amides
CZ297792A3 (en) Cyclically substituted derivatives of imidazolyl-propenoic acid
CZ283482B6 (cs) Trisubstituované bifenyly
CZ72193A3 (en) Biphenylmethyl substituted pyridones
CZ298892A3 (en) Derivatives of imidazolyl-propenoic acid
CZ29693A3 (en) Imidazolyl-substituted amides of phenylacetic acid
CZ51693A3 (en) Propenoyl-imidazole derivatives
CZ62494A3 (en) Hetero-tricyclically substituted derivatives of phenyl-cyclohexanecarboxylic acid, process of their preparation, medicaments in which they are comprised, process for preparing such medicaments and their use
CZ117493A3 (en) Imidazolyl-substituted derivatives of phenylpropionic and cinnamic acids
CZ71094A3 (en) Phenylglycinamides of heterocyclically substituted derivatives of phenylacetic acid, process of their preparation, medicaments in which said derivatives are comprised, process of their preparation and use
US5627285A (en) Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives
SK281028B6 (sk) Imidazolyl substituované deriváty cyklohexánu, spôsob ich výroby, medziprodukt spôsobu výroby, ich použitie na výrobu liečiv a liečivo
CZ16093A3 (en) Sulfonylbenzyl-substituted imidazopyridines
SK27593A3 (en) Cycloalkyl and heterocyclyl substituted derivatives of imidazolylpropenoic acid
SK14493A3 (en) Sulfonylbenzyl substituted imidazoles
PL176171B1 (pl) Trójpodstawione bifenyle i sposób wytwarzania trójpodstawionych bifenyli

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 19991112